Miguel Ángel Santos Santos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Miguel Ángel Santos Santos has a total of 622 co-authors. Here are the top co-authors by number of shared publications:
Bruce L. Miller
A Department of Neurology, Memory and Aging Center , University of California , San Francisco , CA , USA
12 shared publicationsJuan Fortea
Sant Pau Memory Unit, IR SANT PAU, Hospital de la Santa Creu i Sant Pau
10 shared publicationsMaria Luisa Gorno-Tempini
Weill Institute for Neurosciences, Department of Neurology, Memory and Aging Center, University of California, 675 Nelson Rising Lane, Suite 190, San Francisco, CA 94143, USA
9 shared publications- Zachary A. Miller
Edward and Pearl Fein Memory and Aging Center, Department of Neurology, University of California San Francisco , San Francisco , CA 94158
9 shared publications William W. Seeley
A Department of Neurology, Memory and Aging Center , University of California , San Francisco , CA , USA
8 shared publications- Alberto Lleó
Department of Neurology, Institut d’Investigacions Biomèdiques Sant Pau (IIB SANT PAU) - Hospital de Sant Pau, Universitat Autònoma de Barcelona, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
7 shared publications
Latest Publications
- Open Access
Differentiating nonfluent/agrammatic and logopenic primary progressive aphasia in Catalan-Spanish bilinguals by applying multilingual multimodal machine learning (M³L) to connected speech
Background: The nonfluent/agrammatic (nfv) and logopenic (lv) variants of primary progressive aphasia (PPA) disrupt fluency through distinct underlying neurocognitive mechanisms. Differential diagnosis currently requires hours of cognitive-linguistic testing, with additional barriers for bilingual patients due to a shortage of bilingual service providers and a lack of well-established assessment methods. In English speakers, a promising automated approach for differentiating nfvPPA and lvPPA is to derive speech-timing measures and linguistic features from connected speech as input to machine learning (ML) classification algorithms. To our knowledge, this approach has not been evaluated in the context of bilingualism. Methods: Thirty-four Catalan-Spanish simultaneous bilingual patients (lv = 24, nfv = 10) were asked to describe a picture (Western Aphasia Battery Picnic Scene) in both their dominant and non- dominant language. From the participant’s recorded response, we derived four feature sets: speech-timing measures, derived with PRAAT; word-level parameters, derived from corpora; linguistic features, derived with the natural language processing tools SpaCy and CLAN; image-text congruence scores, derived with the vision-language encoder Multilingual-CLIP. Each feature set was fed into classification algorithms for differentiating nfv from lv in participants’ non-dominant and dominant samples. Then, we combined each feature set’s classifier into an ensemble model. We used the McNemar test to determine the statistical significance of differences in classification performance between responses in the non-dominant and dominant language. Results: The best-performing classifier achieved F1 macro scores of 93% (word-level parameters) and 92% (ensemble) in the non-dominant and dominant language, respectively. For all feature sets and ensemble models, classification performance did not significantly differ between the non-dominant and dominant language. Ensemble modeling did not significantly improve classification performance in either language. Conclusions: Taking advantage of recent advances in multilingual multimodal machine learning, we accurately differentiate Spanish-Catalan bilingual individuals with nfvPPA and lvPPA using a largely automated, time-efficient (1–2 minutes), and ecologically valid connected-speech-based approach. Future directions include evaluating this approach on larger datasets balanced by PPA subtype, using automated transcriptions of connected speech. Our study represents a step towards addressing current inequities in PPA differential diagnosis for non-English-speaking bilingual speakers. Trial registration: Data from the clinical trial NCT05741853 was retrospectively analyzed
Open AccessDifferentiating nonfluent/agrammatic and logopenic primary progressive aphasia in Catalan-Spanish bilinguals by applying multilingual multimodal machine learning (M³L) to connected speech
Background: The nonfluent/agrammatic (nfv) and logopenic (lv) variants of primary progressive aphasia (PPA) disrupt fluency through distinct underlying neurocognitive mechanisms. Differential diagnosis currently requires hours of cognitive-linguistic testing, with additional barriers for bilingual patients due to a shortage of bilingual service providers and a lack of well-established assessment methods. In English speakers, a promising automated approach for differentiating nfvPPA and lvPPA is to derive speech-timing measures and linguistic features from connected speech as input to machine learning (ML) classification algorithms. To our knowledge, this approach has not been evaluated in the context of bilingualism. Methods: Thirty-four Catalan-Spanish simultaneous bilingual patients (lv = 24, nfv = 10) were asked to describe a picture (Western Aphasia Battery Picnic Scene) in both their dominant and non- dominant language. From the participant’s recorded response, we derived four feature sets: speech-timing measures, derived with PRAAT; word-level parameters, derived from corpora; linguistic features, derived with the natural language processing tools SpaCy and CLAN; image-text congruence scores, derived with the vision-language encoder Multilingual-CLIP. Each feature set was fed into classification algorithms for differentiating nfv from lv in participants’ non-dominant and dominant samples. Then, we combined each feature set’s classifier into an ensemble model. We used the McNemar test to determine the statistical significance of differences in classification performance between responses in the non-dominant and dominant language. Results: The best-performing classifier achieved F1 macro scores of 93% (word-level parameters) and 92% (ensemble) in the non-dominant and dominant language, respectively. For all feature sets and ensemble models, classification performance did not significantly differ between the non-dominant and dominant language. Ensemble modeling did not significantly improve classification performance in either language. Conclusions: Taking advantage of recent advances in multilingual multimodal machine learning, we accurately differentiate Spanish-Catalan bilingual individuals with nfvPPA and lvPPA using a largely automated, time-efficient (1–2 minutes), and ecologically valid connected-speech-based approach. Future directions include evaluating this approach on larger datasets balanced by PPA subtype, using automated transcriptions of connected speech. Our study represents a step towards addressing current inequities in PPA differential diagnosis for non-English-speaking bilingual speakers. Trial registration: Data from the clinical trial NCT05741853 was retrospectively analyzed
- Open Access
A Spanish grammaticality judgment task for neurodegenerative diseases: inflectional, transitivity, and word order comprehension in PPA and Alzheimer’s Disease
Impairment in the comprehension of morphosyntactic and transitivity information does not feature in current diagnostic guidelines for primary progressive aphasia (PPA) or Alzheimer’s Diseases (AD), despite research reporting delayed sensitivity or insensitivity of these clinical populations to these linguistic domains. Moreover, studies rarely compare all three PPA variants and AD within a single design, and the literature is heavily weighted toward English, whose reduced morphology may not capture the full range of comprehension difficulties these populations experience. We developed a computer-based acceptability judgment task covering comprehension of the nominal and verbal inflection paradigm in Spanish, transitivity and word order. We recruited Spanish-speaking patients diagnosed with non-fluent/agrammatic, logopenic and semantic variants of PPA and typical AD. Psychometric evaluation confirmed good sensitivity, internal consistency and moderate correlation of task accuracy with language and neuropsychological measures. The four clinical groups retained the ability to endorse grammatical sentences but showed selective difficulty rejecting unacceptable ones. AD and the three PPA variants showed impaired comprehension of inflectional and transitivity information, whereas sensitivity to word order was comparatively preserved. Exploratory analyses revealed that short-term memory, working memory, and verbal semantics were differentially associated with sentence evaluation performance within and across groups. VBM analyses identified the left posterior temporal cortex as the main neuroanatomical correlate of grammaticality judgment performance. These findings extend prior English-language research to Spanish, demonstrating that morphosyntactic and transitivity deficits are a robust and cross-linguistically consistent feature of neurodegenerative language decline, and highlighting the importance of developing language-sensitive assessment tools for underrepresented linguistic populations.
Open AccessA Spanish grammaticality judgment task for neurodegenerative diseases: inflectional, transitivity, and word order comprehension in PPA and Alzheimer’s Disease
Impairment in the comprehension of morphosyntactic and transitivity information does not feature in current diagnostic guidelines for primary progressive aphasia (PPA) or Alzheimer’s Diseases (AD), despite research reporting delayed sensitivity or insensitivity of these clinical populations to these linguistic domains. Moreover, studies rarely compare all three PPA variants and AD within a single design, and the literature is heavily weighted toward English, whose reduced morphology may not capture the full range of comprehension difficulties these populations experience. We developed a computer-based acceptability judgment task covering comprehension of the nominal and verbal inflection paradigm in Spanish, transitivity and word order. We recruited Spanish-speaking patients diagnosed with non-fluent/agrammatic, logopenic and semantic variants of PPA and typical AD. Psychometric evaluation confirmed good sensitivity, internal consistency and moderate correlation of task accuracy with language and neuropsychological measures. The four clinical groups retained the ability to endorse grammatical sentences but showed selective difficulty rejecting unacceptable ones. AD and the three PPA variants showed impaired comprehension of inflectional and transitivity information, whereas sensitivity to word order was comparatively preserved. Exploratory analyses revealed that short-term memory, working memory, and verbal semantics were differentially associated with sentence evaluation performance within and across groups. VBM analyses identified the left posterior temporal cortex as the main neuroanatomical correlate of grammaticality judgment performance. These findings extend prior English-language research to Spanish, demonstrating that morphosyntactic and transitivity deficits are a robust and cross-linguistically consistent feature of neurodegenerative language decline, and highlighting the importance of developing language-sensitive assessment tools for underrepresented linguistic populations.
- Open Access
- 12 August 2026
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 18, 1821431
Semantic control across Alzheimer’s disease phenotypes: cognitive mechanisms and neural correlates
Introduction: Semantic cognition, our ability to understand meaning, relies on two distinct but interacting systems: one involved in knowledge representation and another in control processes. This control system is thought to comprise at least two mechanisms: controlled retrieval, which facilitates access to information relevant to a specific goal or context, and selection, which is engaged to resolve competition among multiple simultaneously active semantic representations. The present study aimed at understanding if, and how, controlled semantic cognition is impaired in Alzheimer’s disease (AD), and the neuroanatomical correlates of these deficits. We supposed that in AD, semantic deficits could reflect damage to the retrieval and/or the selection mechanism and could differ according to the clinical phenotype of AD. Methods: Our sample included the typical amnestic (ADtyp, N = 11) clinical presentation as well as the atypical language-dominant variant (logopenic variant primary progressive aphasia, lvPPA, N = 17). 16 healthy controls also took part. We examined object use knowledge in a task that manipulated the levels of both controlled-retrieval and selection semantic control mechanisms. Results: Increased semantic control demands worsened performance in all groups including controls. Both patient groups were impaired in controlled retrieval, but not selection, compared to controls. Furthermore, lvPPA scored consistently lower than controls and ADtyp in all conditions of the experimental task, even the condition with the lowest semantic control demands, pointing to broader semantic difficulties beyond controlled-retrieval and selection… Exploratory analyses suggested the two mechanisms were linked to partially distinct predominant cognitive associations, controlled-retrieval with tests of semantic-knowledge and selection with executive function. Neuroimaging showed partially overlapping but distinct correlates for the two mechanisms, potentially reflecting differing reliance on semantic versus domain-general control brain networks. Conclusion: Our results refine current models of semantic dysfunction in AD, highlighting involvement of both domain-general and more specialized control mechanisms, with potential implications for differential diagnosis, symptom management, and rehabilitation planning.
- 12 August 2026
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 18, 1821431
Open AccessSemantic control across Alzheimer’s disease phenotypes: cognitive mechanisms and neural correlates
Introduction: Semantic cognition, our ability to understand meaning, relies on two distinct but interacting systems: one involved in knowledge representation and another in control processes. This control system is thought to comprise at least two mechanisms: controlled retrieval, which facilitates access to information relevant to a specific goal or context, and selection, which is engaged to resolve competition among multiple simultaneously active semantic representations. The present study aimed at understanding if, and how, controlled semantic cognition is impaired in Alzheimer’s disease (AD), and the neuroanatomical correlates of these deficits. We supposed that in AD, semantic deficits could reflect damage to the retrieval and/or the selection mechanism and could differ according to the clinical phenotype of AD. Methods: Our sample included the typical amnestic (ADtyp, N = 11) clinical presentation as well as the atypical language-dominant variant (logopenic variant primary progressive aphasia, lvPPA, N = 17). 16 healthy controls also took part. We examined object use knowledge in a task that manipulated the levels of both controlled-retrieval and selection semantic control mechanisms. Results: Increased semantic control demands worsened performance in all groups including controls. Both patient groups were impaired in controlled retrieval, but not selection, compared to controls. Furthermore, lvPPA scored consistently lower than controls and ADtyp in all conditions of the experimental task, even the condition with the lowest semantic control demands, pointing to broader semantic difficulties beyond controlled-retrieval and selection… Exploratory analyses suggested the two mechanisms were linked to partially distinct predominant cognitive associations, controlled-retrieval with tests of semantic-knowledge and selection with executive function. Neuroimaging showed partially overlapping but distinct correlates for the two mechanisms, potentially reflecting differing reliance on semantic versus domain-general control brain networks. Conclusion: Our results refine current models of semantic dysfunction in AD, highlighting involvement of both domain-general and more specialized control mechanisms, with potential implications for differential diagnosis, symptom management, and rehabilitation planning.
- 17 July 2026
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 113 (1) , 424-440
Bilingualism and cognition: The impact of age of acquisition, language use, and proficiency in cognitively unimpaired older adults
Background: The positive effect of bilingualism as a cognitive reserve factor in aging remains inconclusive, with inconsistencies often stemming from treating bilingualism as a dichotomous variable rather than a dynamic, multidimensional experience. Objective: To investigate the impact of bilingualism on cognition in cognitively unimpaired older adults, focusing on age of language acquisition (AoA), proficiency, and usage throughout life. Methods: Data from 2415 participants (aged 45–74) from the Alzheimer's and Families (ALFA) study were analyzed. Cognitive assessments included the Mini-Mental State Examination to assess global cognition, semantic verbal fluency for semantic lexical retrieval, Memory Binding Test for verbal episodic memory, and WAIS-IV subtests for processing speed (Coding), visual-spatial reasoning (Visual Puzzles), non-verbal abstract reasoning (Matrix Reasoning), verbal short-term memory and attention (Digit Span Forward) and working memory (Digit Span Backward and Sequencing). We defined three groups based on AoA (Early/Late) and proficiency (High/Low) of Catalan: 1) Early High-Proficiency bilinguals (n = 1559); 2) Late High-Proficiency bilinguals (n = 537) and 3) Late Low-Proficiency bilinguals, primarily Spanish-dominant (n = 319). Results: Early and Late High-Proficiency bilingual groups outperformed Late Low-Proficiency bilinguals in verbal semantic fluency and processing speed. Additionally, Early High-Proficiency bilinguals scored significantly higher in verbal short-term memory than both Late AoA groups. Conclusions: The effects of bilingualism are domain-specific and primarily driven by high proficiency and active language use rather than AoA alone. These findings suggest that maintaining high L2 proficiency throughout the lifespan contributes to cognitive reserve, enhancing attentional control and processing speed in healthy aging.
- 17 July 2026
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 113 (1) , 424-440
Bilingualism and cognition: The impact of age of acquisition, language use, and proficiency in cognitively unimpaired older adults
Background: The positive effect of bilingualism as a cognitive reserve factor in aging remains inconclusive, with inconsistencies often stemming from treating bilingualism as a dichotomous variable rather than a dynamic, multidimensional experience. Objective: To investigate the impact of bilingualism on cognition in cognitively unimpaired older adults, focusing on age of language acquisition (AoA), proficiency, and usage throughout life. Methods: Data from 2415 participants (aged 45–74) from the Alzheimer's and Families (ALFA) study were analyzed. Cognitive assessments included the Mini-Mental State Examination to assess global cognition, semantic verbal fluency for semantic lexical retrieval, Memory Binding Test for verbal episodic memory, and WAIS-IV subtests for processing speed (Coding), visual-spatial reasoning (Visual Puzzles), non-verbal abstract reasoning (Matrix Reasoning), verbal short-term memory and attention (Digit Span Forward) and working memory (Digit Span Backward and Sequencing). We defined three groups based on AoA (Early/Late) and proficiency (High/Low) of Catalan: 1) Early High-Proficiency bilinguals (n = 1559); 2) Late High-Proficiency bilinguals (n = 537) and 3) Late Low-Proficiency bilinguals, primarily Spanish-dominant (n = 319). Results: Early and Late High-Proficiency bilingual groups outperformed Late Low-Proficiency bilinguals in verbal semantic fluency and processing speed. Additionally, Early High-Proficiency bilinguals scored significantly higher in verbal short-term memory than both Late AoA groups. Conclusions: The effects of bilingualism are domain-specific and primarily driven by high proficiency and active language use rather than AoA alone. These findings suggest that maintaining high L2 proficiency throughout the lifespan contributes to cognitive reserve, enhancing attentional control and processing speed in healthy aging.
- Open Access
- 14 July 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (1) , e218180
Clinical Impact and Prognostic Value of Alzheimer Disease Biomarkers in the Very Old
Alzheimer disease (AD) is increasingly viewed as a clinical-biological continuum, but the utility of biomarkers in individuals aged ≥80 years, the so-called "very old," remains uncertain, because of concerns about its clinical usefulness. This study aimed to determine the clinical impact and prognostic value of AD biomarkers in very old individuals. We performed a retrospective longitudinal cohort study within the Sant Pau Initiative on Neurodegeneration (SPIN, Barcelona, Spain), a memory clinic-based research cohort. Patients were referred from primary care physicians or community neurologists for evaluation within a public universal health care catchment area. We included SPIN participants evaluated between October 2013 and May 2024 who were aged ≥80 years and had mild cognitive impairment (MCI) at the baseline visit. Participants underwent standardized clinical and neuropsychological assessments and had CSF and plasma biomarker measurements available. AD biology was defined by the CSF phosphorylated tau at threonine 181/amyloid-β 42 ratio. Plasma phosphorylated tau at threonine 217 (p-Tau217) was evaluated for (1) diagnostic accuracy for AD biology and (2) prognostic associations with longitudinal cognitive change (Mini-Mental State Examination [MMSE]) and progression to dementia. Analyses used linear mixed-effects models for MMSE trajectories and Cox regression for dementia conversion. A total of 167 participants were included (mean age 82.3 years, 59% women) with a mean follow-up of 35.8 months; the ones with AD biology (n = 116, 69%) had worse baseline cognitive performance, particularly in memory, compared with those without (Cohen d = 0.34, p = 0.03). Plasma p-Tau217 showed excellent diagnostic accuracy for detecting AD biology (0.93, 95% CI 0.88-0.98; cutoff 0.19 pg/mL; sensitivity 94.5%; specificity 84%). Over time, participants with AD biology declined faster on the MMSE than those without (-0.47 vs -0.18 points per year; p < 0.01). Cox models showed an increased risk of progression to a dementia stage among individuals with higher plasma p-Tau217 concentrations (hazard ratio 1.49, 95% CI 1.05-2.13, p = 0.026). In very old individuals with MCI, AD biology (CSF) and plasma p-Tau217 identify individuals at higher risk of faster cognitive decline and progression to dementia. Limitations of this study include the single-center design and the modest sample size.
- 14 July 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (1) , e218180
Open AccessClinical Impact and Prognostic Value of Alzheimer Disease Biomarkers in the Very Old
Alzheimer disease (AD) is increasingly viewed as a clinical-biological continuum, but the utility of biomarkers in individuals aged ≥80 years, the so-called "very old," remains uncertain, because of concerns about its clinical usefulness. This study aimed to determine the clinical impact and prognostic value of AD biomarkers in very old individuals. We performed a retrospective longitudinal cohort study within the Sant Pau Initiative on Neurodegeneration (SPIN, Barcelona, Spain), a memory clinic-based research cohort. Patients were referred from primary care physicians or community neurologists for evaluation within a public universal health care catchment area. We included SPIN participants evaluated between October 2013 and May 2024 who were aged ≥80 years and had mild cognitive impairment (MCI) at the baseline visit. Participants underwent standardized clinical and neuropsychological assessments and had CSF and plasma biomarker measurements available. AD biology was defined by the CSF phosphorylated tau at threonine 181/amyloid-β 42 ratio. Plasma phosphorylated tau at threonine 217 (p-Tau217) was evaluated for (1) diagnostic accuracy for AD biology and (2) prognostic associations with longitudinal cognitive change (Mini-Mental State Examination [MMSE]) and progression to dementia. Analyses used linear mixed-effects models for MMSE trajectories and Cox regression for dementia conversion. A total of 167 participants were included (mean age 82.3 years, 59% women) with a mean follow-up of 35.8 months; the ones with AD biology (n = 116, 69%) had worse baseline cognitive performance, particularly in memory, compared with those without (Cohen d = 0.34, p = 0.03). Plasma p-Tau217 showed excellent diagnostic accuracy for detecting AD biology (0.93, 95% CI 0.88-0.98; cutoff 0.19 pg/mL; sensitivity 94.5%; specificity 84%). Over time, participants with AD biology declined faster on the MMSE than those without (-0.47 vs -0.18 points per year; p < 0.01). Cox models showed an increased risk of progression to a dementia stage among individuals with higher plasma p-Tau217 concentrations (hazard ratio 1.49, 95% CI 1.05-2.13, p = 0.026). In very old individuals with MCI, AD biology (CSF) and plasma p-Tau217 identify individuals at higher risk of faster cognitive decline and progression to dementia. Limitations of this study include the single-center design and the modest sample size.
- Open Access
- 29 May 2026
- Published by Wiley in Alzheimer's & Dementia
- Vol. 22 (5) , e71507
Peak width of skeletonized mean diffusivity reveals early and multifactorial white matter injury across sporadic and Down syndrome–associated Alzheimer's disease
INTRODUCTION: This study investigates the evolution with disease progression and pathological correlates of peak width of skeletonized mean diffusivity (PSMD), a sensitive diffusion magnetic resonance imaging (MRI) marker of microvascular white matter (WM) injury, in sporadic Alzheimer's disease (sAD) and Down syndrome (DS)–associated AD (DSAD). METHOD: This cross‐sectional study included 150 euploid controls, 118 subjects with sAD, and 228 DS adults (34.65% with symptomatic AD). PSMD was derived from 3T‐MRI diffusion tensor imaging. Associations with sociodemographic, clinical stage, cerebrospinal fluid (CSF), and small vessel disease markers were examined. RESULTS: PSMD correlated with age in all groups, showing a stronger association in DS, with alterations apparent 15 years before the population's dementia age at onset. In euploid and DS, higher PSMD correlated with AD severity, CSF‐neurofilament light chain (NfL), microbleeds, and WM hyperintensities (WMH). PSMD abnormalities were more frequent than WMH, especially in DS. DISCUSSION: PSMD is a sensitive early biomarker of WM injury across sAD and DSAD, preceding symptom onset and capturing multifactorial disease processes.
- 29 May 2026
- Published by Wiley in Alzheimer's & Dementia
- Vol. 22 (5) , e71507
Open AccessPeak width of skeletonized mean diffusivity reveals early and multifactorial white matter injury across sporadic and Down syndrome–associated Alzheimer's disease
INTRODUCTION: This study investigates the evolution with disease progression and pathological correlates of peak width of skeletonized mean diffusivity (PSMD), a sensitive diffusion magnetic resonance imaging (MRI) marker of microvascular white matter (WM) injury, in sporadic Alzheimer's disease (sAD) and Down syndrome (DS)–associated AD (DSAD). METHOD: This cross‐sectional study included 150 euploid controls, 118 subjects with sAD, and 228 DS adults (34.65% with symptomatic AD). PSMD was derived from 3T‐MRI diffusion tensor imaging. Associations with sociodemographic, clinical stage, cerebrospinal fluid (CSF), and small vessel disease markers were examined. RESULTS: PSMD correlated with age in all groups, showing a stronger association in DS, with alterations apparent 15 years before the population's dementia age at onset. In euploid and DS, higher PSMD correlated with AD severity, CSF‐neurofilament light chain (NfL), microbleeds, and WM hyperintensities (WMH). PSMD abnormalities were more frequent than WMH, especially in DS. DISCUSSION: PSMD is a sensitive early biomarker of WM injury across sAD and DSAD, preceding symptom onset and capturing multifactorial disease processes.
- Open Access
Evidence for bilingualism as a cognitive reserve factor in biomarker-confirmed Alzheimer’s disease
INTRODUCTION: Bilingualism is a proposed cognitive reserve factor that delays symptom onset in Alzheimer’s disease (AD), though current evidence lacks biomarker confirmation. This retrospective study examined bilingualism’s association with symptom onset across AD clinical stages, including biomarker-confirmed cases. METHODS: Participants from the Sant Pau Memory Unit spanning amnestic mild cognitive impairment (MCI), amnestic dementia, and biomarker-confirmed AD were analyzed, with balanced representation of active and passive Spanish-Catalan bilinguals. Linear regression models evaluated associations between bilingualism and reported age at symptom onset, controlling for education, sex, and disease severity. RESULTS: Active bilingualism was associated with delayed symptom onset in amnestic MCI (2.21 years), amnestic dementia (1.42 years), and biomarker-confirmed AD (1.45 years; p s < .05). Higher education was associated with earlier onset, likely representing healthcare seeking behavior. DISCUSSION: Bilingualism protects against earlier symptom manifestation in MCI and AD, supporting bilingualism as a contributor to cognitive reserve.
Open AccessEvidence for bilingualism as a cognitive reserve factor in biomarker-confirmed Alzheimer’s disease
INTRODUCTION: Bilingualism is a proposed cognitive reserve factor that delays symptom onset in Alzheimer’s disease (AD), though current evidence lacks biomarker confirmation. This retrospective study examined bilingualism’s association with symptom onset across AD clinical stages, including biomarker-confirmed cases. METHODS: Participants from the Sant Pau Memory Unit spanning amnestic mild cognitive impairment (MCI), amnestic dementia, and biomarker-confirmed AD were analyzed, with balanced representation of active and passive Spanish-Catalan bilinguals. Linear regression models evaluated associations between bilingualism and reported age at symptom onset, controlling for education, sex, and disease severity. RESULTS: Active bilingualism was associated with delayed symptom onset in amnestic MCI (2.21 years), amnestic dementia (1.42 years), and biomarker-confirmed AD (1.45 years; p s < .05). Higher education was associated with earlier onset, likely representing healthcare seeking behavior. DISCUSSION: Bilingualism protects against earlier symptom manifestation in MCI and AD, supporting bilingualism as a contributor to cognitive reserve.
- 26 March 2026
- Published by Springer Nature in Brain Structure and Function
- Vol. 231 (3) , 45
Impaired semantic word learning in primary progressive aphasia
- 26 March 2026
- Published by Springer Nature in Brain Structure and Function
- Vol. 231 (3) , 45
Impaired semantic word learning in primary progressive aphasia
- Open Access
Bilingualism’s protective effects in Alzheimer’s disease: Mechanisms of resilience and resistance
INTRODUCTION: Bilingualism is among several lifestyle factors associated with protection against cognitive decline, yet the biological mechanisms through which it exerts these effects remain poorly understood. METHODS: We compared neuropsychological functioning and biofluid markers of brain health between active ( n = 280) and passive ( n = 287) Spanish-Catalan bilinguals with biomarker-confirmed Alzheimer’s disease (AD). RESULTS: Active bilinguals outperformed passive bilinguals on tests assessing attention/executive functions, language, and visuospatial/visuomotor functioning, demonstrating resilience given the same AD biological stage across participants. Active bilinguals also exhibited significant differences in cerebrospinal fluid and plasma biomarkers of amyloid burden and neuroinflammation, suggesting both resilience and resistance to AD pathophysiologic mechanisms. DISCUSSION: The protective effects of bilingual experience may engage both resilience and resistance to AD pathophysiology mechanisms. These results underscore the importance of capturing bilingualism in aging cohorts and the study of how lifestyle and sociocultural factors shape the biological expression of neurodegenerative disease.
Open AccessBilingualism’s protective effects in Alzheimer’s disease: Mechanisms of resilience and resistance
INTRODUCTION: Bilingualism is among several lifestyle factors associated with protection against cognitive decline, yet the biological mechanisms through which it exerts these effects remain poorly understood. METHODS: We compared neuropsychological functioning and biofluid markers of brain health between active ( n = 280) and passive ( n = 287) Spanish-Catalan bilinguals with biomarker-confirmed Alzheimer’s disease (AD). RESULTS: Active bilinguals outperformed passive bilinguals on tests assessing attention/executive functions, language, and visuospatial/visuomotor functioning, demonstrating resilience given the same AD biological stage across participants. Active bilinguals also exhibited significant differences in cerebrospinal fluid and plasma biomarkers of amyloid burden and neuroinflammation, suggesting both resilience and resistance to AD pathophysiologic mechanisms. DISCUSSION: The protective effects of bilingual experience may engage both resilience and resistance to AD pathophysiology mechanisms. These results underscore the importance of capturing bilingualism in aging cohorts and the study of how lifestyle and sociocultural factors shape the biological expression of neurodegenerative disease.
- Open Access
- 24 January 2026
- Published by Elsevier in The Journal Of Prevention of Alzheimer's Disease
- Vol. 13 (3) , 100486
Potential role of MRI to optimize clinical trial design for progressive supranuclear palsy and corticobasal degeneration
- 24 January 2026
- Published by Elsevier in The Journal Of Prevention of Alzheimer's Disease
- Vol. 13 (3) , 100486
Open AccessPotential role of MRI to optimize clinical trial design for progressive supranuclear palsy and corticobasal degeneration